Name | Tonapofylline |
---|---|
Synonyms |
3-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-bicyclo[2.2.2]oct-1-yl]-proprionic acid
4-(2,3,6,7-TETRAHYDRO-2,6-DIOXO-1,3-DIPROPYL-1H-PURIN-8-YL)-BICYCLO[2.2.2]OCTANE-1-PROPANOIC ACID 3-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-bicyclo[2.2.2]oct-1-yl]-propionic acid |
Description | Tonapofylline (BG 9928) is an orally active and selective adenosine A1 receptor antagonist with a Ki of 7.4 nM for human adenosine A1 receptor (hA1), which displays 915-fold selectivity versus human adenosine A2A receptor and 12-fold selectivity versus human adenosine A2B receptor and is used in development for the treatment of heart failure[1][2]. |
---|---|
Related Catalog | |
Target |
Ki: 7.4 nM (Human adenosine A1 receptor)[1] |
References |
Molecular Formula | C22H32N4O4 |
---|---|
Molecular Weight | 416.51400 |
Exact Mass | 416.24200 |
PSA | 109.98000 |
LogP | 3.16310 |
Storage condition | -20°C |